Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH).
Aging-related inflammation emerges as a shared driver of pre-cancerous blood cell growth, opening doors to prevention strategies.
This expert review by investigators from Moffitt, Dana-Farber, San Raffaele, and Mayo Clinic synthesizes clonal dynamics across monoclonal B-cell lymphocytosis (MBL), MGUS, and clonal hematopoiesis (CH), identifying shared biological principles governing progression to overt malignancy. The unifying framework highlights aging-associated inflammation and microenvironmental remodeling as common drivers and supports stratified precision-prevention strategies for these prevalent pre-malignant states.
What the study was
- Study design
- expert narrative review
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Seminars in Cancer Biology
Why it surfaced
High-impact expert synthesis from leading hematology centers, proposing a new 'precision prevention' paradigm for pre-malignant clonal states; directly relevant to T1 hematologic malignancy watchlist and future early intervention strategies.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.